1 Min Read
Feb 16 (Reuters) - Fountain Biopharma Inc:
* Says it got patent in U.S for methods for producing recombinant glycoproteins with modified
Source text in Chinese: goo.gl/5rscSN
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.